Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 15.

Lupus Hits Hardest Among Poor (CME/CE)
(MedPage Today) -- Systemic lupus erythematosus disproportionately affects individuals of lower socioeconomic status, who not only have greater prevalence of disease but who also face difficulties in access to care, an analysis of Medicaid data showed. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 1, 2013 Category: Primary Care Source Type: news

Takeda And Resolve Therapeutics Enter Autoimmune Partnership
Takeda Pharmaceutical Company Limited ("Takeda") andResolve Therapeutics, LLC("Resolve") today jointly announced that they have entered into a partnership to develop compounds for the treatment of lupus (also known as Systemic Lupus Erythematosus, or SLE) and other autoimmune diseases. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - March 1, 2013 Category: Pharmaceuticals Source Type: news

JCI early table of contents for Mar. 1, 2013
(Journal of Clinical Investigation) The following release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Mar. 1, 2013, in the JCI: Coordinating adaptive responses to cardiac stress; A nanogel-based therapy for the treatment of lupus; and many more. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 1, 2013 Category: Global & Universal Source Type: news

A nanogel-based treatment for lupus
(Journal of Clinical Investigation) In this issue of the Journal of Clinical Investigation, Tarek Fahmy and colleagues at Yale University report the development of a nanogel-based delivery system that targets an immunosuppressive drug (mycophenolic acid) directly to tissues associated with immune cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 1, 2013 Category: Global & Universal Source Type: news

Takeda and Resolve Therapeutics Enter Autoimmune Partnership
Partners to Develop Novel Nuclease Proteins for Lupus   OSAKA, Japan and SEATTLE, Feb. 27, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and Resolve Therapeutics, LLC ("Resolve") today jointly announced that they... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2013 Category: Pharmaceuticals Source Type: news

What Causes Constipation?
Discussion Constipation generally is defined as infrequent or painful defecation. Constipation can be very disturbing to the patient and family who believe the stools are too infrequent, too hard or too difficult to pass. Most children develop constipation after the child begins to associate pain (e.g. a hard bowel movement) with defecation. The child then begins to withhold the stools trying to decrease the defecation discomfort. As stool withholding continues, the rectum dilates and gradually accommodates with the normal defecation urge disappearing. Passing large hard stools infrequently reinforces the defecation pain. ...
Source: PediatricEducation.org - February 25, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news

New Enzyme Discovered That Acts As Innate Immunity Sensor
Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections. The studies identify a new enzyme that acts as a sensor of innate immunity - the body's first line of defense against invaders - and describe a novel cell signaling pathway. This pathway detects foreign DNA or even host DNA when it appears in a part of the cell where DNA should not be... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 19, 2013 Category: Consumer Health News Tags: Lupus Source Type: news

Researchers reveal new enzyme that acts as innate immunity sensor
Two studies by UT Southwestern researchers could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections. (Source: UT Southwestern Medical Center News)
Source: UT Southwestern Medical Center News - February 16, 2013 Category: Hospital Management Source Type: news

UTSW researchers identify new enzyme that acts as innate immunity sensor
(UT Southwestern Medical Center) Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2013 Category: Global & Universal Source Type: news

Horizon scanning: Development of tabalumab for rheumatoid arthritis halted
Source: Reuters Health Area: News Eli Lilly and Co have halted development of the experimental anti-B-cell activating (BAFF) human monoclonal antibody tabalumab for rheumatoid arthritis following data from a late-stage trial which showed the drug was unlikely to prove effective.   Tabalumab will continue to be tested in late-stage development as a treatment for systemic lupus erythematosus, and in mid-stage development for multiple myeloma. (Source: NeLM - News)
Source: NeLM - News - February 8, 2013 Category: Drugs & Pharmacology Source Type: news

Lilly Discontinues Phase 3 Rheumatoid Arthritis Program for Tabalumab Based on Efficacy Results
Decision not based on safety concerns; Phase 3 lupus program continues as planned INDIANAPOLIS, Feb. 7, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today that it will discontinue the Phase 3 rheumatoid arthritis (RA)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2013 Category: Pharmaceuticals Source Type: news

Scientists Find A Key Element Of Lupus, Suggesting Better Drug Targets
A team led by scientists at The Scripps Research Institute (TSRI) has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 7, 2013 Category: Consumer Health News Tags: Lupus Source Type: news

Lupus Plus Cranial Neuropathy: A Treatment to TryLupus Plus Cranial Neuropathy: A Treatment to Try
Dr. Jon Kay discusses the challenging case of a patient with systemic lupus erythematosus now presenting with cranial nerve dysfunction. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2013 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news

High-risk pregnancy on the rise: Older moms, larger families and heavier women are driving the need for specialty care
Perinatologists are helping women start and grow families when a pregnancy is considered “high risk” due to age or other factors. These factors include multiple miscarriages, carrying multiples such as twins or triplets, high blood pressure, diabetes, lupus and obesity, which is more common in older mothers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 6, 2013 Category: Science Source Type: news

Myeloma, Lupus, Rheumatoid Arthritis Patients May One Day Benefit From Research On Immune Cell 'Survival' Gene
Scientists have identified the gene essential for survival of antibody-producing cells, a finding that could lead to better treatments for diseases where these cells are out of control, such as myeloma and chronic immune disorders. The discovery that a gene called Mcl-1 is critical for keeping this vital immune cell population alive was made by researchers at Melbourne's Walter and Eliza Hall Institute. Associate Professor David Tarlinton, Dr Victor Peperzak and Dr Ingela Vikstrom from the institute's Immunology division led the research, which was published in Nature Immunology... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 6, 2013 Category: Consumer Health News Tags: Lymphoma / Leukemia / Myeloma Source Type: news

National Lupus Information Tour: Dallas - Fort Worth
The Lupus Foundation Of America Unveils The 'Cruel Mystery' of Lupus to Dallas-fort Worth - Lupus Foundation of America's New Survey Shows Most Americans Know Little to Nothing About Disease; Tour Brings a 45-foot Bus with Interactive Experience of Lupus To DFW. (Source: Disabled World)
Source: Disabled World - February 5, 2013 Category: Disability Tags: 2013 Events Source Type: news

No Evidence That Lupus Drugs Lead to Cancer, Says Study
Title: No Evidence That Lupus Drugs Lead to Cancer, Says StudyCategory: Health NewsCreated: 2/4/2013 2:35:00 PMLast Editorial Review: 2/5/2013 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 5, 2013 Category: Rheumatology Source Type: news

Scientists find a key element of lupus, suggesting better drug targets
Scientists have identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 5, 2013 Category: Science Source Type: news

No Evidence That Lupus Drugs Lead to Cancer, Says Study
Concerns that cyclophosphamide, other meds raise lymphoma risk not borne out by research (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 4, 2013 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Pharmacy, Rheumatology, News, Source Type: news

No Evidence That Lupus Drugs Lead to Cancer, Says Study
Concerns that cyclophosphamide, other meds raise lymphoma risk not borne out by researchSource: HealthDay Related MedlinePlus Pages: Lupus, Lymphoma (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 4, 2013 Category: Consumer Health News Source Type: news

Scientists find a key element of lupus, suggesting better drug targets
(Scripps Research Institute) A team led by scientists at the Scripps Research Institute has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 4, 2013 Category: Global & Universal Source Type: news

No Evidence That Lupus Drugs Lead to Cancer, Says Study
Concerns that cyclophosphamide, other meds raise lymphoma risk not borne out by research (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 4, 2013 Category: Cancer & Oncology Source Type: news

Contraception for Women With Systemic Lupus ErythematosusContraception for Women With Systemic Lupus Erythematosus
What types of contraceptive methods are most effective and appropriate for women with SLE? Journal of Family Planning and Reproductive Health Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 31, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Merck Serono and Feinstein Institute to Partner on Pre-clinical Program in Inflammatory Diseases
From PR Newswire Europe (English) (January 29, 2013) GENEVA, Switzerland, January 29, 2013 /PRNewswire/ -- - Collaboration to focus on research and development of antibodies for the treatment of systemic lupus erythematosus (SLE) Merck Serono, a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2013 Category: Pharmaceuticals Source Type: news

Lupus Drugs Do Not Increase Lymphoma Risk Lupus Drugs Do Not Increase Lymphoma Risk
The risk for lymphoma is not increased by lupus drugs or disease activity, McGill researchers conclude. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 28, 2013 Category: Consumer Health News Tags: Rheumatology News Source Type: news

No Significant Cancer Risk For Patients From Lupus Drugs
People who take immunosuppressive drugs to treat lupus do not necessarily increase their cancer risk according to new research led by scientists at the Research Institute of the McGill University Health Centre (RI-MUHC). This landmark study, which was published in Annals of the Rheumatic Diseases this month, addresses long-standing fears of a link between lupus medication and cancer... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 28, 2013 Category: Consumer Health News Tags: Lupus Source Type: news

What is Acute Hemorrhagic Edema of Infancy?
Discussion The differential diagnosis for acute hemorrhagic edema of infancy (AHEI) is similar to purpura and includes: Vascultitis Henoch-Schonlein purpura (HSP) Drug induced Kawasaki disease Rocky Mountain Spotted Fever Trauma induced Infectious Disease Meningococcemia Sepsis Dermatologic Erythema multiforme Gianotti Crosti Hemorrhagic urticaria Sweet’s syndrome Child maltreatment Neonatal lupus Learning Point Acute hemorrhagic edema of infancy (AHEI, also called Seidlmayer or postinfectious cockade purpura, medallion-like purpura, or Finkelstein’s disease) is an uncommon, self-limited cutaneous leukocy...
Source: PediatricEducation.org - January 28, 2013 Category: Pediatrics Authors: Donna M. D'Alessandro, M.D. Tags: Uncategorized Source Type: news

Link Between Immune Cell Death Defects And Autoimmune Diseases
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues. The finding suggests that these so-called autoimmune diseases could be treated with existing medications that force long-lived immune system cells to die. In the development of the immune system, some cells are produced that have the potential to attack the body's own tissues, causing autoimmune disease... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 25, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Research: Lupus drugs carry no significant cancer risk for patients
(McGill University Health Centre) People who take immunosuppressive drugs to treat lupus do not necessarily increase their cancer risk according to new research led by scientists at the Research Institute of the McGill University Health Centre. This landmark study, which was published in Annals of the Rheumatic Diseases this month, addresses long-standing fears of a link between lupus medication and cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2013 Category: Global & Universal Source Type: news

Argos Therapeutics Enrolls Initial Patients in Pivotal Phase 3 ADAPT Study
  Argos Therapeutics Enrolls Initial Patients in Pivotal Phase 3 ADAPT Study AGS-003, first fully personalized, dendritic-based immunotherapy  being evaluated in combination with targeted therapy for mRCC Visit ADAPTkidneycancer.com & Follow on Twitter @ADAPTkdnycancer DURHAM, N.C. – January 15, 2012 – Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced that the first patients hav...
Source: Kidney Cancer Association - January 23, 2013 Category: Cancer & Oncology Source Type: news

Argos Therapeutics Enrolls Initial Patients in Pivotal Phase 3 ADAPT Study
  Argos Therapeutics Enrolls Initial Patients in Pivotal Phase 3 ADAPT Study AGS-003, first fully personalized, dendritic-based immunotherapy  being evaluated in combination with targeted therapy for mRCC Visit ADAPTkidneycancer.com & Follow on Twitter @ADAPTkdnycancer DURHAM, N.C. – January 15, 2012 – Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced that the first patients have been enr...
Source: Kidney Cancer Association - January 23, 2013 Category: Urology & Nephrology Source Type: news

Immune cell death defects linked to autoimmune diseases
(Walter and Eliza Hall Institute) Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 22, 2013 Category: Global & Universal Source Type: news

Altering Gut Microbes Protects Against Disease, Supporting The 'Hygiene Hypothesis'
Early life exposure to normal bacteria of the GI tract (gut microbes) protects against autoimmune disease in mice, according to research published on-line in the journal Science. The study may also have uncovered reasons why females are at greater risk of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and lupus compared to males. Researchers from The Hospital for Sick Children (SickKids) found that when female mice at high risk of autoimmune (type 1) diabetes were exposed to normal gut bacteria from adult male mice, they were strongly protected against the disease... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 21, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

GI tract bacteria may protect against autoimmune disease
Early life exposure to normal bacteria of the GI tract (gut microbes) protects against autoimmune disease in mice, according to new research. The study may also have uncovered reasons why females are at greater risk of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and lupus compared to males. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 17, 2013 Category: Science Source Type: news

Crusted Scabies
A 40-year-old woman who had been receiving prednisone and azathioprine for the treatment of systemic lupus erythematosus complained of a widespread, intensely pruritic, heavily scaling skin rash. (Source: Consultant Live)
Source: Consultant Live - January 17, 2013 Category: Primary Care Source Type: news

GI tract bacteria may protect against autoimmune disease
(Helmholtz Association of German Research Centres) Early life exposure to normal bacteria of the GI tract (gut microbes) protects against autoimmune disease in mice, according to research published online in the Jan. 17 edition of Science. The study may also have uncovered reasons why females are at greater risk of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and lupus compared to males. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2013 Category: Global & Universal Source Type: news

January eFactor
Birnbaum gives keynote at environmental health meeting in India Resnick elected AAAS Fellow Suk honored for leadership by Society of Toxicology Grassroots well water testing initiative reveals high levels of arsenic and radon ASU appoints Halden to lead new Center for Environmental Security NIEHS Partners gather in Friendship Heights Faculty position takes postdoc to remote Arctic community Former NIEHS fellow pursues a career in mentoring postdocs Environmental Polymorphisms Registry gets new leader NIEHS employees recognized by NIH OD Stokes honored by U.S. Public Health Service 2012 papers of the year NTP bo...
Source: Environmental Factor - NIEHS Newsletter - January 2, 2013 Category: Environmental Health Source Type: news

Drug Shows Promise for Lupus Skin Conditions
Title: Drug Shows Promise for Lupus Skin ConditionsCategory: Health NewsCreated: 12/8/2012 11:00:00 AMLast Editorial Review: 12/10/2012 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - December 10, 2012 Category: Rheumatology Source Type: news